Akebia Therapeutics | AKBA - Bruttoergebnis Vom Umsatz





Bruttoergebnis Vom Umsatz Veränderung Datum
Acadia Pharmaceuticals USD 279.64M 36.37M 2026-06
Agios Pharmaceuticals USD 19.43M 1.34M 2026-03
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Amgen USD 5.87B 1.02B 2026-03
Ardelyx USD 89.66M 24.7M 2026-03
Astellas Pharma JPY 482.54B 38.28B 2026-06
AstraZeneca USD 12.86B 251M 2026-06
Bayer EUR 6.33B 1.84B 2026-06
BioMarin Pharmaceutical USD 713.42M 142.21M 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Exelixis USD 608.03M 17.17M 2026-06
Fresenius Medical Care EUR 1.31B 130.98M 2026-06
GlaxoSmithKline GBP 6.51B 757M 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Ironwood Pharmaceuticals USD 85.24M 44.1M 2025-06
J&J USD 18.55B 1.31B 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Medical Developments International AUD 7.35M 7.37M 2025-06
Moderna USD -566M 792M 2026-03
Nektar Therapeutics USD 10.86M 10.95M 2026-03
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pharma Mar EUR 44.87M 5.63M 2026-06
Prothena USD 51.08M 51.06M 2026-03
PTC Therapeutics USD 232.94M 84.56M 2026-03
Qiagen NV USD 340.39M 30.78M 2026-06
Regeneron Pharmaceuticals USD 3.71B 778.2M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sanofi EUR 8.71B 602M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tectonic Therapeutic USD 0 0 2025-03
Tilray USD 57.47M 10.16M 2025-06
Vanda Pharmaceuticals USD 50.6M 5.5M 2024-12
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03